CHMP5 and COVID-19: Serum anti-SARS-CoV-2 neutralizing antibody (nAb) titer and serum anti-Spike binding antibody (bAb) concentration are supported as correlates of protection (CoPs)1,2 against symptomatic SARS-CoV-2 infection3.